Contact Us | Directions | Referring a Patient

A leading comprehensive brain tumor program, using molecular diagnostic, gene expression analysis,
cutting edge clinical trials and advanced medical informatics to customize treatment plans for cancer patients.
 Latest Headlines
•Astrocytoma (Brain Tumor, Glioma) (ThirdAge)
Tue, 09 Feb 2010 03:39:15 GMT
•QIAGEN Unit And Pfizer Enter Into An Agreement To Develop A Companion Diagnostic For Brain Tumor Patients (PharmaceuticalOnline)
Tue, 09 Feb 2010 09:09:44 GMT
•Account to benefit Dale Carpenter (Yakima Herald-Republic)
Tue, 09 Feb 2010 07:25:57 GMT
•QIAGEN Unit And Pfizer Enter Into An Agreement To Develop A Companion Diagnostic For Brain Tumor Patients (Medical News Today)
Sat, 06 Feb 2010 13:18:10 GMT
•Carpenter on mend after brain tumor removed (Yakima Herald-Republic)
Wed, 03 Feb 2010 07:09:00 GMT
•Neurosurgeon-Scientist Eric C. Holland, MD, PhD to Join Health Enhancement Products Scientific Advisory Board (GlobeNewswire via Yahoo! Finance)
Mon, 08 Feb 2010 17:35:01 GMT
•The Inspirational Meghan McCarthy (Tewksbury Town Crier)
Sun, 07 Feb 2010 10:26:36 GMT
•Lesage community raises money for kindergarten student (The Huntington Herald-Dispatch)
Sun, 07 Feb 2010 04:45:23 GMT
•QIAGEN Unit And Pfizer Enter Into An Agreement To Develop A Companion Diagnostic For Brain Tumor Patients (Business Wire via Yahoo! Finance)
Thu, 04 Feb 2010 21:00:00 GMT
•Pediatric cancer charity gives $173,275 to groups, families (The Morning Call)
Tue, 09 Feb 2010 08:57:06 GMT

* Headlines are from industry sponsored news wires, medical journals and established news organizations from around the world . Please consider the source of the content when viewing the story.
   
 
10th Annual UCLA Brain Tumor Conference
March 19th-20th 2010

Join brain cancer survivors, family members, friends and health care professionals at the 2010 UCLA Brain Tumor Conference, hosted by the UCLA Neuro-Oncology Program.

This FREE conference will offer participants the opportunity to hear leading healthcare professionals speak about the latest treatments for brain tumors. Through this conference, the Neuro-Oncology Program promotes the sharing of information and experience between brain tumor survivors, their families, friends and health care professionals.

• Conference Schedule  • Registration: Sign Up

Improving clinical outcomes in glioblastoma brain tumors with genetic analysis

In this study, featured in the New England Journal of Medicine, glioblastomas patients who were treated with gefitinib or erlotinib, were found to be responsive to EGFR kinase inhibitors and strongly associated with coexpression by the tumor of EGFRvIII and PTEN.



UCLA Neuro-Oncology & SiliconMED Launch Online Tool Correlating Gene Expression Levels with Overall Survival of Brain Cancer Patients

Genomic analysis is a powerful new tool permitting unprecedented insights into how brain tumors form and has been enabled primarily through microarray technology. ProbeSetAnalyzer.com, a new web based tool, is aiming to help clinicians and researchers take the massive amount of data created by microarrays and better visualize gene expression levels and how they relate to the overall survival of brain cancer patients.

Most Popular
.  Clinical Trials
.  Probe Set Analyzer
.  Our Team
.  Brain Tumor Translational Resource
.  Art of the Brain
.  Personalized Medicine using Targeted Molecular Therapy
.  Online Giving
.  How our Glioblastoma Multiforme Patients Perform

Spring / Summer 2010
Breakthroughs



Prognostic significance of growth kinetics in newly diagnosed glioblastomas revealed by combining serial imaging with a novel biomathematical model.
Cancer Res
PMID: 19934335 ; 69(23):9133-40

Bevacizumab for recurrent ependymoma.
Neurology
73(20):1677-80.PMID: 19917990

Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma.
J Clin Oncol.
(28):4733-40; PMID: 19720927

Fyn and SRC are effectors of oncogenic epidermal growth factor receptor signaling in glioblastoma patients.
Cancer Res
PMID: 19690143 ; 69(17):6889-98

Stem cell associated gene expression in glioblastoma multiforme: relationship to survival and the subventricular zone.
J Neurooncology
PMID: 19655089

All Information content hearof is designed for educational purposes only and is not for the purpose of rendering medical advice or professional services. The information provided should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. Any specific questions you may have regarding an individual's medical condition should be directed to the individual's primary care physician or other attending physician. In addition, if you have or suspect you may have a health problem, you should consult your health care provider.

Portions Copyright (Search, Chart, Content Publishing Tools, Photography, ProviderIQ) 1998-2010 SiliconMED North America

ProviderIQ is a registered trademark of SiliconMED North America and used by permission.

Copyright © 2010 UCLA Neuro-Oncology Program | Timothly Cloughesy MD; Director
All Rights Reserved.

[Content Published:2/9/2010 5:21:45 AM PST]